<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: FDA Nixes Wyeth Schizophrenia Drug</title>
	<atom:link href="http://www.pharmalot.com/2007/08/fda-nixes-wyeth-schizophrenia-drug/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2007/08/fda-nixes-wyeth-schizophrenia-drug/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 19:51:00 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Only Psychology &#187; Blog Archive &#187; Wyeth Schizophrenia Drug, Bifeprunox, Suffers Setback</title>
		<link>http://www.pharmalot.com/2007/08/fda-nixes-wyeth-schizophrenia-drug/#comment-16708</link>
		<dc:creator>Only Psychology &#187; Blog Archive &#187; Wyeth Schizophrenia Drug, Bifeprunox, Suffers Setback</dc:creator>
		<pubDate>Sat, 11 Aug 2007 03:24:02 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2007/08/fda-nixes-wyeth-schizophrenia-drug/#comment-16708</guid>
		<description>[...] The U.S. Food and Drug Administration (FDA) let Wyeth and its partner, Solvay Pharmaceuticals, know that their newest schizophrenia drug, bifeprunox, needed further research to gain FDA approval. Pharmalot has the story. [...]</description>
		<content:encoded><![CDATA[<p>[...] The U.S. Food and Drug Administration (FDA) let Wyeth and its partner, Solvay Pharmaceuticals, know that their newest schizophrenia drug, bifeprunox, needed further research to gain FDA approval. Pharmalot has the story. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Wyeth Schizophrenia Drug, Bifeprunox, Suffers Setback - World of Psychology</title>
		<link>http://www.pharmalot.com/2007/08/fda-nixes-wyeth-schizophrenia-drug/#comment-16661</link>
		<dc:creator>Wyeth Schizophrenia Drug, Bifeprunox, Suffers Setback - World of Psychology</dc:creator>
		<pubDate>Fri, 10 Aug 2007 13:45:15 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/2007/08/fda-nixes-wyeth-schizophrenia-drug/#comment-16661</guid>
		<description>[...] The U.S. Food and Drug Administration (FDA) let Wyeth and its partner, Solvay Pharmaceuticals, know that their newest schizophrenia drug, bifeprunox, needed further research to gain FDA approval. Pharmalot has the story. [...]</description>
		<content:encoded><![CDATA[<p>[...] The U.S. Food and Drug Administration (FDA) let Wyeth and its partner, Solvay Pharmaceuticals, know that their newest schizophrenia drug, bifeprunox, needed further research to gain FDA approval. Pharmalot has the story. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.148 seconds -->

